Patient no. | Age (y) | Initial cancer stage | Gleason score | PSA (ng/mL) | Treatment | 68Ga-PSMA-11 | 68Ga-RM2 |
1 | 83 | II | 5 + 4 | 16.2 | HT + IMRT | Retroperitoneal LNs | Retroperitoneal LNs |
2 | 69 | II | 3 + 4 | 6.0 | Prostatectomy | Retroperitoneal LNs | Retroperitoneal LNs |
3 | 75 | IV | 4 + 5 | 36.5 | Prostatectomy | Retroperitoneal LNs, pelvic LN | Retroperitoneal LNs, pelvic LN |
4 | 67 | III | 3 + 3 | 6.7 | Brachytherapy + HT | Vas deferens, pelvic LN | Negative |
5 | 72 | III | 4 + 3 | 3.5 | RT | Supraclavicular LN | Supraclavicular LN |
6 | 81 | I | 3 + 4 | 7.4 | Prostatectomy | Pelvic LNs, seminal vesicle | Pelvic LNs, seminal vesicle |
7 | 73 | III | 4 + 4 | 18.2 | Prostatectomy | Mediastinal LNs, retroperitoneal LNs, pelvic LNs, multiple bone lesions | Mediastinal LNs, retroperitoneal LNs, pelvic LNs, multiple bone lesions |
HT = hormone therapy; IMRT = intensity-modulated radiation therapy; LN = lymph node; RT = radiation therapy.